Skip to main content
Clinical Trials/JPRN-UMIN000040614
JPRN-UMIN000040614
Recruiting
未知

A retrospective study on the therapeutic effect of tocilizumab on COVID-19 - J-COVID-RT

Japanese Red Cross Medical Center0 sites20 target enrollmentJune 1, 2020
ConditionsCOVID-19

Overview

Phase
未知
Intervention
Not specified
Conditions
COVID-19
Sponsor
Japanese Red Cross Medical Center
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2020
End Date
December 31, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Cases where tocilizumab administration was judged to be inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials